§ COMPARE REGULATORS

PMDA vs TGA: Medical Device Regulatory Comparison

Compare the medical device registration pathways, classification, and regulatory requirements of PMDA (Japan) vs TGA (Australia).

PMDA

Pharmaceuticals and Medical Devices Agency (Japan)

Japan

Japan's PMDA conducts scientific reviews of medical device applications under the PMD Act. Japan uses a four-class system with three pathways: Todokede (notification) for Class I, Ninsho (third-party

CLASSES

Class I, II, III, IV

PATHWAY

Todokede / Ninsho / Shonin

KEY FUNCTIONS
  • Shonin pre-market approval
  • Ninsho third-party certification
  • QMS inspection (MHLW Ordinance 169)
  • PMDA consultation (Taimen Joshu)
  • Foreign Manufacturer Registration

TGA

Therapeutic Goods Administration (Australia)

Australia

The TGA regulates medical devices in Australia under the Therapeutic Goods Act 1989. Australia uses a risk-based classification system aligned with GHTF/IMDRF. The TGA is an MDSAP participating author

CLASSES

Class I, IIa, IIb, III, AIMD

PATHWAY

ARTG inclusion via conformity assessment

KEY FUNCTIONS
  • ARTG registration
  • Conformity assessment
  • MDSAP participation
  • Adverse event reporting
  • Post-market surveillance

MedFlux monitors both PMDA and TGA in real time — every regulatory change, safety alert, and market signal delivered in under 90 seconds.

COMPARE LIVE DATA FREE →

§ OTHER COMPARISONS